Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYBiothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial OfficerPREV STORYCORRECTING AND REPLACING: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update